Clinical Trials Logo

Clinical Trial Summary

Medication reconciliation (MR) is essential to limit drug-related problems that occur during care transitions in and out of care institutions. Pharmacy-led medication reconciliation has been shown to reduce medication discrepancies, preventable harm and hospital readmissions. However, these consultations are time-consuming. The Erasmus Medical Center is currently developing a mobile-based patient portal. After receiving an invitation to perform medication reconciliation in the app, patients can review their medication and allergies at home. Next, pharmacy technicians manually verify all patient-entered data on completeness and quality. The investigators hypothesize that mobile-based medication reconciliation results in increased patient insight. Yet, it is unknown if mobile-based medication reconciliation is feasible, saves time, and is of high quality. Therefore, the primary study objectives are to assess (1) the feasibility of patients performing medication reconciliation using a mobile-based patient portal, (2) the time investment of pharmacy technicians in mobile-based medication reconciliation (and related costs), in comparison to standard practice, and (3) the quality of patients' pre-verified medication lists. The secondary study objective is to assess patients' and pharmacy technicians' acceptability of performing medication reconciliation using a mobile-based patient portal. This is a prospective quality evaluation study assessing mobile-based medication reconciliation. All adult patients (18 years or older) who are admitted to (a selection of) clinical ward in Erasmus Medical Center and who are asked to complete medication reconciliation are eligible. In the patient app, patients review ('pre-verify') their medications and allergies, after which pharmacy technicians check and manually approve ('verify') all patient-entered data and determine whether a follow-up interview is needed. Feasibility is defined as the successful completion rate of digital medication reconciliation, and the need for additional interviews. Time investment by pharmacy technicians (and related costs) are determined by timing the duration of all patient-bound medication reconciliation-related tasks, both in standard care and when using mobile-based reconciliation. The quality of verification is determined by comparing patients' pre-verified medication list to pharmacy technician-verified lists. Acceptability is defined as the perceived usability of medication reconciliation by patients and by pharmacy technicians.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06040151
Study type Observational
Source Erasmus Medical Center
Contact Martijn Brands, MD
Phone 0031205665675
Email m.r.brands@erasmusmc.nl
Status Not yet recruiting
Phase
Start date October 2023
Completion date May 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03943121 - The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps N/A
Completed NCT04151004 - Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation N/A
Not yet recruiting NCT02968082 - The Effects of Preoperative Scopolamine Patch Application on the Postoperative Nausea and Vomiting in MVD Surgery Phase 4
Completed NCT01240967 - To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function Phase 1
Recruiting NCT06373614 - The Effect of Foot Massage and Bed Bath on Individuals With Cancer N/A
Recruiting NCT06396442 - Patient Worries Previous to Dental Treatment
Recruiting NCT05088161 - Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
Completed NCT03153579 - LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders Phase 2
Completed NCT03790839 - Drug Interaction Study Between Dorzagliatin and Sitagliptin Phase 1
Completed NCT02882672 - Changes in Adiponectin and Cardiovascular Disease Risk Factors in Overweight Patients Phase 1
Withdrawn NCT03837418 - DESIGNING A PROGRAMMING LANGUAGE FOR PATIENT-ORIENTED PRESCRIPTIONS (POP-PL)
Completed NCT03282630 - The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic Rhinitis N/A
Recruiting NCT00001711 - Magnetic Resonance Imaging (MRI) Ofl Volunteers
Completed NCT02820168 - Designing a Programming Language for Patient-Oriented Prescriptions
Completed NCT01706744 - Effect of Discharge Via an Intermediate Care Unit N/A
Completed NCT04584554 - Enhancing the Transition From Hospital to Home for Patients With Traumatic Brain Injury and Families N/A
Completed NCT05660707 - Patients Who Underwent Surgical Procedures State of Readiness for Discharge
Completed NCT04632277 - Is Mg do Improve the Glycemic Control in Patients Drink a Desalinate Water N/A
Completed NCT05576701 - Laughter Therapy Application in Hemodialysis Patients N/A
Completed NCT03790787 - Drug Interaction Study Between Dorzagliatin and Empagliflozin Phase 1